A normoglykaemia jelentosege a diabetes mellitus kezeleseben

25 ev nemzetkozi es hazai tapasztalatai

Translated title of the contribution: Importance of normoglycaemia in the therapy of diabetes mellitus: 25 years of experience

P. Stella, Z. Kerényi, P. Turbucz, A. Tabák, G. Tamás

Research output: Contribution to journalArticle

Abstract

For many years the primary therapeutic aim in diabetes mellitus was to avoid acut complications. This view has slowly changed during the past 25 years, and trying to achieve normoglycaemia has become the main target of diabetes therapy accepted worldwide and supported by results of several prospective clinical trials in both types of diabetes. Our team has been following this principle for the past 20 years. According to our results it seems that throughout the long-term implementation of these methods, not only the intermediate outcome improves, but also less diabetes related endpoints will be experienced in the future, such as blindness or end-stage renal failure.

Original languageHungarian
Pages (from-to)34-39
Number of pages6
JournalLege Artis Medicinae
Volume10
Issue number1
Publication statusPublished - 2000

Fingerprint

Diabetes Mellitus
Blindness
Chronic Kidney Failure
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A normoglykaemia jelentosege a diabetes mellitus kezeleseben : 25 ev nemzetkozi es hazai tapasztalatai. / Stella, P.; Kerényi, Z.; Turbucz, P.; Tabák, A.; Tamás, G.

In: Lege Artis Medicinae, Vol. 10, No. 1, 2000, p. 34-39.

Research output: Contribution to journalArticle

@article{a610d27cc1a444048522bfb41c6c7ac7,
title = "A normoglykaemia jelentosege a diabetes mellitus kezeleseben: 25 ev nemzetkozi es hazai tapasztalatai",
abstract = "For many years the primary therapeutic aim in diabetes mellitus was to avoid acut complications. This view has slowly changed during the past 25 years, and trying to achieve normoglycaemia has become the main target of diabetes therapy accepted worldwide and supported by results of several prospective clinical trials in both types of diabetes. Our team has been following this principle for the past 20 years. According to our results it seems that throughout the long-term implementation of these methods, not only the intermediate outcome improves, but also less diabetes related endpoints will be experienced in the future, such as blindness or end-stage renal failure.",
keywords = "Normoglycaemia, Type 1 diabetes mellitus, Type 2 diabetes mellitus",
author = "P. Stella and Z. Ker{\'e}nyi and P. Turbucz and A. Tab{\'a}k and G. Tam{\'a}s",
year = "2000",
language = "Hungarian",
volume = "10",
pages = "34--39",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "1",

}

TY - JOUR

T1 - A normoglykaemia jelentosege a diabetes mellitus kezeleseben

T2 - 25 ev nemzetkozi es hazai tapasztalatai

AU - Stella, P.

AU - Kerényi, Z.

AU - Turbucz, P.

AU - Tabák, A.

AU - Tamás, G.

PY - 2000

Y1 - 2000

N2 - For many years the primary therapeutic aim in diabetes mellitus was to avoid acut complications. This view has slowly changed during the past 25 years, and trying to achieve normoglycaemia has become the main target of diabetes therapy accepted worldwide and supported by results of several prospective clinical trials in both types of diabetes. Our team has been following this principle for the past 20 years. According to our results it seems that throughout the long-term implementation of these methods, not only the intermediate outcome improves, but also less diabetes related endpoints will be experienced in the future, such as blindness or end-stage renal failure.

AB - For many years the primary therapeutic aim in diabetes mellitus was to avoid acut complications. This view has slowly changed during the past 25 years, and trying to achieve normoglycaemia has become the main target of diabetes therapy accepted worldwide and supported by results of several prospective clinical trials in both types of diabetes. Our team has been following this principle for the past 20 years. According to our results it seems that throughout the long-term implementation of these methods, not only the intermediate outcome improves, but also less diabetes related endpoints will be experienced in the future, such as blindness or end-stage renal failure.

KW - Normoglycaemia

KW - Type 1 diabetes mellitus

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0033961185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033961185&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 34

EP - 39

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 1

ER -